Limarin 70 Capsule contains Silymarin 70 mg, a standardized extract derived from the seeds of the milk thistle plant (Silybum marianum), widely recognized for its hepatoprotective properties. Silymarin acts as a potent antioxidant, scavenging free radicals and reducing oxidative stress in hepatic cells, thereby promoting liver cell regeneration and protecting against toxin-induced liver damage. It is commonly indicated for the management of various liver disorders, including alcoholic liver disease, non-alcoholic fatty liver disease, viral hepatitis, and drug-induced hepatotoxicity. Limarin 70 Capsule supports liver function by stabilizing cell membranes, enhancing protein synthesis, and modulating inflammatory responses within hepatic tissue. Additionally, it may improve bile flow, aiding in the detoxification process and digestion. The capsule formulation ensures convenient oral administration and optimal bioavailability. Limarin 70 is generally well-tolerated, with minimal adverse effects reported; however, it should be used under medical supervision, especially in patients with known allergies to milk thistle or related compounds. It is contraindicated in individuals with hypersensitivity to any component of the formulation. Limarin 70 Capsule may be used as an adjunct to conventional therapies to support liver health and improve clinical outcomes in patients with hepatic impairment.